Study on bioavailability of complex chlorzoxazone dispersible tablet in healthy volunteers
Xhao Li-mei
Abstract
Xhao Li-mei
Abstract
OBJECTIVE To compare the pharinacokinetics and relative bioavailability of complex chlorzoxazone tablet. METHODS In randomized crossover design,asingle dose complex chlorzoxazone tablet was given to 18 healthy male volunteers. The plasma concentrations of chlorzoxazone and paracetamol were determined by HPLC method. RESULTS The pharmacokinetie parameters of the two products were included: c max were(19.7±5 9 )and( 19.4 ± 5.9)μg·mL-1;t1/2were( 1.3 ± 0.5)and( 1.1 ±0.2)h;AUC were(50.6± 18.3)and(52.8± 19 8) μg·h·mL 1 , respectively. The mean relative bioavailability of the two tablets was(96.6 ± 8.8)% .CONCLUSION The results suggested that these two products were ralative bioavailability.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To compare the pharinacokinetics and relative bioavailability of complex chlorzoxazone tablet. METHODS In randomized crossover design,asingle dose complex chlorzoxazone tablet was given to 18 healthy male volunteers. The plasma concentrations of chlorzoxazone and paracetamol were determined by HPLC method. RESULTS The pharmacokinetie parameters of the two products were included: c max were(19.7±5 9 )and( 19.4 ± 5.9)μg·mL-1;t1/2were( 1.3 ± 0.5)and( 1.1 ±0.2)h;AUC were(50.6± 18.3)and(52.8± 19 8) μg·h·mL 1 , respectively. The mean relative bioavailability of the two tablets was(96.6 ± 8.8)% .CONCLUSION The results suggested that these two products were ralative bioavailability.
Key concepts: Chlorzoxazone, Bioavailability, Crossover study, Chemistry, Bioequivalence, Pharmacology, Plasma concentration, Chromatography